All News #Library
Biotech
Bluejay`s Brelovitug Achieves 100% Virologic Response in Trial
10 Nov 2025 //
GLOBENEWSWIRE
Bluejay Begins AZURE-2 Phase 3 Trial for Chronic Hepatitis D
04 Sep 2025 //
GLOBENEWSWIRE
Bluejay’s Brelovitug Get FDA Breakthrough For Hepatitis Delta
21 Jan 2025 //
GLOBENEWSWIRE
Bluejay’s BJT-778 Achieves 100% Response in Chronic Hepatitis D
15 Nov 2024 //
GLOBENEWSWIRE
Bluejay: Positive Phase 2 BJT-778 Data In Chronic Hepatitis D At EASL
05 Jun 2024 //
GLOBENEWSWIRE
Bluejay Receipt of PRIME Designation from(EMA) for BJT-778
25 Mar 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support